KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Minority Interest (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Minority Interest data on record, last reported at $41.3 million in Q4 2025.

  • For Q4 2025, Minority Interest changed 0.33% year-over-year to $41.3 million; the TTM value through Dec 2025 reached $41.3 million, changed 0.33%, while the annual FY2025 figure was $41.3 million, 0.33% changed from the prior year.
  • Minority Interest reached $41.3 million in Q4 2025 per CRL's latest filing, up from $4.9 million in the prior quarter.
  • Across five years, Minority Interest topped out at $57.8 million in Q1 2024 and bottomed at $4.9 million in Q3 2025.
  • Average Minority Interest over 5 years is $40.9 million, with a median of $41.2 million recorded in 2024.
  • Peak YoY movement for Minority Interest: soared 107.89% in 2021, then tumbled 87.99% in 2025.
  • A 5-year view of Minority Interest shows it stood at $53.0 million in 2021, then decreased by 19.96% to $42.4 million in 2022, then surged by 33.69% to $56.7 million in 2023, then decreased by 27.5% to $41.1 million in 2024, then rose by 0.33% to $41.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Minority Interest were $41.3 million in Q4 2025, $4.9 million in Q3 2025, and $40.0 million in Q2 2025.